Drag a card by its title · ⚙ to size, swap or remove

The company

Leverage Shares 2X Long FIX Daily ETF

FIXX · Cboe BZX · fund

We hold no 150-day reading for FIXX.

SEC filings

Statistics

Rotation: not in the set
Weeks in an uptrend: —
Insider buys, 12 months: $60.0M
Insider sales, 12 months: $856K
Officials’ trades on record: 0
Institutions holding: 0

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3

Sale orders, 12 months11

Buyers · sellers3 · 3

Who	Did	Shares	Traded
Lee KalowskiCFO and President	sold	1,301at $8.32	6 Oct 2026filed 14 Oct 2026
Shelia M. VioletteChief Scientific Officer	sold	917at $8.32	6 Oct 2026filed 14 Oct 2026
Jodie Pope MorrisonCEO	sold	3,221at $8.32	6 Oct 2026filed 14 Oct 2026
Shelia M. VioletteChief Scientific Officer	sold	2,798at $16.56	25 Aug 2026filed 27 Aug 2026
Jodie Pope MorrisonCEO	sold	9,845at $16.56	25 Aug 2026filed 27 Aug 2026
Lee KalowskiCFO and President	sold	3,972at $16.56	25 Aug 2026filed 27 Aug 2026
Orbimed Advisors LlcDirector, 10% owner	bought	1,250,000at $8.00	28 May 2026filed 1 Jun 2026
Orbimed Advisors LlcDirector, 10% owner	bought	625,000at $8.00	28 May 2026filed 1 Jun 2026
Diyong XuDirector, 10% owner	bought	1,250,000at $8.00	28 May 2026filed 1 Jun 2026
Diyong XuDirector, 10% owner	bought	625,000at $8.00	28 May 2026filed 1 Jun 2026
Shelia M. VioletteChief Scientific Officer	sold	2,815at $4.51	25 Feb 2026filed 27 Feb 2026
Jodie Pope MorrisonCEO	sold	9,896at $4.51	25 Feb 2026filed 27 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders0

New · exited0 · 0

Reported value$0

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change

News

No headline names it lately.

Everyone who traded it

Jodie Pope Morrison CEO · last 6 Oct 20260 · 5

Lee Kalowski CFO and President · last 6 Oct 20260 · 5

Shelia M. Violette Chief Scientific Officer · last 6 Oct 20260 · 4

Isaac Manke Director · last 30 Jun 20260 · 0

Arthur Tzianabos Director · last 12 Jun 20260 · 13

David S. Grayzel Director · last 12 Jun 20260 · 0

Diyong Xu Director, 10% owner · last 12 Jun 20261 · 0

Kathleen Laporte Director · last 12 Jun 20260 · 0

Mark T. Iwicki Director · last 12 Jun 20260 · 0

Mary Thistle Director · last 12 Jun 20260 · 0

Sven Ante Lundberg Director · last 12 Jun 20260 · 0

ORBIMED ADVISORS LLC Director, 10% owner · last 28 May 20261 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202531.5%

Free cash flow marginFY 2025 · to 31 Dec 2025-62.4%

Return on capital employedFY 2025 · to 31 Dec 202533.5%

Cash conversionFY 2025 · to 31 Dec 2025-112%

Interest coverFY 2025 · to 31 Dec 202516.02×

Research spendFY 2025 · to 31 Dec 202535.6%

Share count trendFY 2025 · to 1 Mar 202613.8%

Cash and equivalentsFY 2025 · to 31 Dec 2025$48.3M

Free cash flowFY 2025 · to 31 Dec 2025−$33.5M

Analyst forecasts

No analyst forecasts yet.